MedTrace Logo

Glucosamine Sulfate Bioavailability

NCT06971484 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2025-05-22

No results posted yet for this study

Summary

This study aims to compare the pharmacokinetics and bioavailability of crystalline glucosamine sulfate and regular glucosamine sulfate using a double-blind, randomized, crossover design.

Conditions

  • Bioavailability and Pharmacokinetics

Interventions

DIETARY_SUPPLEMENT

Crystalline glucosamine sulfate

A maximum single dose of 1500mg of glucosamine sulfate in a caplet.

DIETARY_SUPPLEMENT

Regular glucosamine sulfate

A maximum single dose of 1500mg of glucosamine sulfate in hard gel capsules.

Sponsors & Collaborators

  • Isura

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-01-06
Primary Completion
2025-03-28
Completion
2025-04-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06971484 on ClinicalTrials.gov